Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary Recent experimental data, clinical, genetic and transcriptome evidence from patients converge to suggest a key role of interleukin-1β (IL-1β) in the pathogenesis of Kawasaki Disease (KD). However, the molecular mechanisms involved in the development of cardiovascular lesions during KD vasculitis are still unknown. Here, we investigated intestinal barrier function in KD vasculitis, and observed evidence of intestinal permeability and elevated circulating secretory IgA (sIgA) in KD patients, as well as elevated sIgA and IgA deposition in vascular tissues in a mouse model of KD vasculitis. Targeting intestinal permeability corrected gut permeability, prevented IgA deposition and ameliorated cardiovascular pathology in the mouse model. Using genetic and pharmacologic inhibition of IL-1β signaling, we demonstrated that IL-1β lay upstream of disrupted intestinal barrier function, subsequent IgA vasculitis development, and cardiac inflammation. Targeting mucosal barrier dysfunction and the IL-1β pathway may also be applicable to other IgA-related diseases including IgA vasculitis and IgA nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 3×
“Dysfunction of the intestinal barrier function, manifested by increased flux across TJdependent pores or through a TJ-independent pathway, is a risk factor for a variety of disorders (Turner, 2009).”
BackgroundInfluentialIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 2×
“Intestinal permeability can be altered by a range of factors, including viral infection, mucus barrier degradation and epithelial damage or change in the microbiome composition (Bischoff et al., 2014).”
BackgroundA conditional knockout resource for the genome-wide study of mouse gene function
Skarnes, W. C., Rosen, B., West, A. P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A. O., Thomas, M., Harrow, J., Cox, T., et al. (2011) · Nature · doi:10.1038/nature10163 · Cited by 1,708
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
New concepts in the generation and functions of IgA
Pabst, O. (2012) · Nature reviews. Immunology · doi:10.1038/nri3322 · Cited by 656 · cited 1×
“IgA, the predominant antibody isotype produced in the GI tract, is translocated in mucosal secretions as polyreactive dimers, sIgA, and protects the intestinal epithelium from toxins and pathogenic microorganisms (Pabst, 2012).”
BackgroundIgG endopeptidase in highly sensitized patients undergoing transplantation
Jordan, S. C., Lorant, T., Choi, J., Kjellman, C., Winstedt, L., Bengtsson, M., Zhang, X., Eich, T., Toyoda, M., Eriksson, B.-M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612567 · Cited by 377 · cited 1×
“Recently, IgG endopeptidase treatment has been successfully used to block donor pathogenic IgG and complement activation in sensitized renal transplant patients (Jordan et al., 2017).”
BackgroundWang, S., Charbonnier, L.-M., Noval Rivas, M., Georgiev, P., Li, N., Gerber, G., Bry, L., & Chatila, T. A. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.014 · Cited by 161
Cited by
Pouletty, M., Borocco, C., Ouldali, N., Caseris, M., Basmaci, R., Lachaume, N., Bensaid, P., Pichard, S., Kouider, H., Morelle, G., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217960 · Cited by 542
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Gut barrier disruption and chronic disease
Martel, J., Chang, S.-H., Ko, Y.-F., Hwang, T.-L., Young, J. D., & Ojcius, D. M. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.01.002 · Cited by 514
Kabeerdoss, J., Pilania, R. K., Karkhele, R., Kumar, T. S., Danda, D., & Singh, S. (2021) · Rheumatology International · doi:10.1007/s00296-020-04749-4 · Cited by 352
Kawasaki disease: pathophysiology and insights from mouse models
Noval Rivas, M., & Arditi, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0426-0 · Cited by 310
Self-citationLi, S., Chen, F., Zou, Y., Ning, L., Zhang, G., Zhang, S., & Yao, Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-4809 · Cited by 10
Metadata
- Authors
- Noval Rivas, M., Wakita, D., Franklin, M. K., Carvalho, T. T., Abolhesn, A., Gomez, A. C., Fishbein, M. C., Chen, S., Lehman, T. J., Sato, K., Shibuya, A., Fasano, A., Kiyono, H., Abe, M., Tatsumoto, N., Yamashita, M., Crother, T. R., Shimada, K., & Arditi, M.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 51
- Issue
- 3
- Pages
- 508-521.e6
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2971267622
- Cited by
- 131
- References
- 7
- FWCI
- 14.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.